PT  - JOURNAL ARTICLE
AU  - Mahalingam, Devalingam
AU  - Alistar, Angela
AU  - Mita, Alain
AU  - Kim, Jeongjun
AU  - Ahn, Hyunji
AU  - Choi, Jinho
AU  - Ryu, Seung-Hee
AU  - Ahn, Jiye
AU  - Choi, Bae Jung
AU  - Kang, Hwankyu
AU  - Yang, Yeong-In
AU  - Lee, Seung-Joo
AU  - Jeon, Borami
AU  - Proniuk, Stefan
AU  - Nam, Kiyean
AU  - El-Khoueiry, Anthony
TI  - 651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0651
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A742--A742
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A742.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A742.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.